Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

History of Bipolar Disorder and the Risk of Dementia: A Systematic Review and Meta-Analysis.

Diniz BS, Teixeira AL, Cao F, Gildengers A, Soares JC, Butters MA, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 2017 Apr;25(4):357-362. doi: 10.1016/j.jagp.2016.11.014. Epub 2017 Jan 4. Review.

PMID:
28161155
2.

Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification.

Lauterbach EC.

Neural Regen Res. 2016 Nov;11(11):1712-1726. doi: 10.4103/1673-5374.194708. Review.

3.

Mood disorders in the elderly: prevalence, functional impact, and management challenges.

Valiengo Lda C, Stella F, Forlenza OV.

Neuropsychiatr Dis Treat. 2016 Aug 24;12:2105-14. doi: 10.2147/NDT.S94643. eCollection 2016. Review.

4.

A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts.

Dell'Osso L, Del Grande C, Gesi C, Carmassi C, Musetti L.

Neuropsychiatr Dis Treat. 2016 Jul 11;12:1687-703. doi: 10.2147/NDT.S106479. eCollection 2016. Review.

5.

A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force.

Sajatovic M, Strejilevich SA, Gildengers AG, Dols A, Al Jurdi RK, Forester BP, Kessing LV, Beyer J, Manes F, Rej S, Rosa AR, Schouws SN, Tsai SY, Young RC, Shulman KI.

Bipolar Disord. 2015 Nov;17(7):689-704. doi: 10.1111/bdi.12331. Epub 2015 Sep 19. Review.

6.

Acute renal and neurotoxicity in older lithium users: How can we manage and prevent these events in patients with late-life mood disorders?

Laliberté V, Yu C, Rej S.

J Psychiatry Neurosci. 2015 Jul;40(4):E29-30. No abstract available.

7.

Illness progression as a function of independent and accumulating poor prognosis factors in outpatients with bipolar disorder in the United States.

Post RM, Altshuler LL, Leverich GS, Nolen WA, Kupka R, Grunze H, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Rowe M.

Prim Care Companion CNS Disord. 2014 Dec 18;16(6). doi: 10.4088/PCC.14m01677. eCollection 2014.

8.
9.

Bipolar disorders in DSM-5: strengths, problems and perspectives.

Angst J.

Int J Bipolar Disord. 2013 Aug 23;1:12. doi: 10.1186/2194-7511-1-12. eCollection 2013.

10.

The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain.

Maixner DW, Weng HR.

J Pharm Pharmacol (Los Angel). 2013;1(1):001.

11.

Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder.

Gildengers AG, Butters MA, Aizenstein HJ, Marron MM, Emanuel J, Anderson SJ, Weissfeld LA, Becker JT, Lopez OL, Mulsant BH, Reynolds CF 3rd.

Bipolar Disord. 2015 May;17(3):248-56. doi: 10.1111/bdi.12260. Epub 2014 Sep 25.

12.

Cognitive Consequences of Aging with HIV: Implications for Neuroplasticity and Rehabilitation.

Vance DE, McDougall GJ Jr, Wilson N, Debiasi MO, Cody SL.

Top Geriatr Rehabil. 2014 Jan;30(1):35-45.

13.

Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders.

Forlenza OV, De-Paula VJ, Diniz BS.

ACS Chem Neurosci. 2014 Jun 18;5(6):443-50. doi: 10.1021/cn5000309. Epub 2014 May 6. Review.

14.

Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders.

Diniz BS, Machado-Vieira R, Forlenza OV.

Neuropsychiatr Dis Treat. 2013;9:493-500. doi: 10.2147/NDT.S33086. Epub 2013 Apr 12.

15.

Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder.

Chiu CT, Wang Z, Hunsberger JG, Chuang DM.

Pharmacol Rev. 2013 Jan 8;65(1):105-42. doi: 10.1124/pr.111.005512. Print 2013 Jan. Review.

16.

Clinical implications of cognitive function in bipolar disorder.

Kumar CT, Frangou S.

Ther Adv Chronic Dis. 2010 May;1(3):85-93. doi: 10.1177/2040622310374678.

17.

Using lithium as a neuroprotective agent in patients with cancer.

Khasraw M, Ashley D, Wheeler G, Berk M.

BMC Med. 2012 Nov 2;10:131. doi: 10.1186/1741-7015-10-131. Review.

18.

Chronic lithium feeding reduces upregulated brain arachidonic acid metabolism in HIV-1 transgenic rat.

Ramadan E, Basselin M, Chang L, Chen M, Ma K, Rapoport SI.

J Neuroimmune Pharmacol. 2012 Sep;7(3):701-13. doi: 10.1007/s11481-012-9381-0. Epub 2012 Jul 4.

19.

Bipolar disorder: clinical perspectives and implications with cognitive dysfunction and dementia.

Lopes R, Fernandes L.

Depress Res Treat. 2012;2012:275957. doi: 10.1155/2012/275957. Epub 2012 May 28.

20.

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.

de la Monte SM.

Curr Alzheimer Res. 2012 Jan;9(1):35-66. Review.

Supplemental Content

Support Center